Clariane Shares Dip 2.31% at Midday, Key Support in Sight
Clariane shares fell 2.31% at midday this Tuesday, March 3, trading at 3.976 euros compared to 4.07 euros at the previous close. This decline is part of a downward movement affecting all European markets, which are down by 1 to 3% due to geopolitical tensions related to the conflict in Iran. However, the group specializing in dependency care shows a positive performance over longer horizons.
Short-Term Momentum Fades as Shares Dip Below Moving Average
Clariane shares are now trading slightly below their 20-day moving average, which stands at 3.91 euros, after having hovered around it in recent sessions. This drop below this dynamic threshold indicates a waning of the short-term upward trend, although the stock remains above its 50-day moving average (3.88 euros). The RSI, at 54, remains in the neutral zone, indicating neither oversold nor overbought conditions. On the downside, the next technical level to watch is at the support identified at 3.74 euros, which also corresponds to the lower boundary of the Bollinger Bands (3.71 euros). Over three months, the increase of 3.76% and the rise of 8.04% over a year show that the overall trajectory of the stock remains positive, despite today's dip.
Key Upcoming Dates for Clariane Shareholders
The next major event for Clariane shareholders is scheduled for April 23 with the release of the first quarter 2026 revenue. This indicator will allow to assess the commercial dynamics of the group in its various care and accommodation activities. The general meeting is scheduled for May 12, followed by the semi-annual results expected on July 29. Furthermore, the stock displays a beta of 0.17, indicating historically low sensitivity to overall market movements. This characteristic is partly verified this Tuesday: the decline of 2.31% remains contained compared to the more pronounced correction observed in some European cyclical stocks and indices, in a context of high volatility linked to the surge in energy prices.
